Search

Your search keyword '"Drug approval -- Technology application"' showing total 17 results
Start Over Descriptor "Drug approval -- Technology application" Journal globenewswire
17 results on '"Drug approval -- Technology application"'

1. ProLynx announces a publication proposing that a long-acting prodrug of SN-38 could be effective in treating Sacituzumab Govitecan-Resistant Tumors

Subjects
Tumors -- Drug therapy, Biological products -- Technology application, Drug approval -- Technology application, Monoclonal antibodies -- Technology application, Technology application, Banking, finance and accounting industries, Business, Trodelvy (Medication)
Abstract

SAN FRANCISCO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- ProLynx Inc., a biotech company with a unique technology for tunable half-life extension of drugs, announced publication of a paper entitled 'Could [...]

Published
2024

2. RetinalGeniX(TM) Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs

Subjects
Macular degeneration -- Technology application, Drugs -- Technology application -- Intellectual property, Drug approval -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

PETALUMA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX(TM) Technologies Inc. (OTCQB:RTGN) ('RetinalGeniX' or the 'Company'), today announced that it has submitted two provisional patent applications to the US Patent [...]

Published
2023

3. Aphaia Pharma Announces Enrollment of First Patient in Phase 2 Study of APH-012 for Chronic Weight Management in Individuals with Obesity

Subjects
United States. Food and Drug Administration -- Technology application, Medical research -- Technology application, Medicine, Experimental -- Technology application, Obesity -- Care and treatment, Drugs -- Vehicles, Drug approval -- Technology application, Drug delivery systems -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

ZUG, Switzerland, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Aphaia Pharma, a clinical-stage biopharmaceutical company harnessing precision-targeted drug delivery technology for the treatment and prevention of metabolic diseases, today announced that [...]

Published
2022

4. TriLink BioTechnologies(R) Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea

Subjects
Food -- Safety and security measures, Biotechnology -- Technology application, RNA -- Technology application, Drug approval -- Technology application, Vaccines -- Product development, Technology application, Banking, finance and accounting industries, Business
Abstract

SAN DIEGO, Oct 04, 2021 (GLOBE NEWSWIRE via COMTEX) -- TriLink BioTechnologies ('TriLink'), a Maravai LifeSciences company (Nasdaq: MRVI) and a leader in the production of nucleic acids for research, [...]

Published
2021

5. GigaGen Publishes Research on Company's Recombinant Hyperimmunes in Nature Biotechnology

Subjects
Grifols S.A. -- Technology application, Biological products -- Technology application, Biotechnology -- Technology application, Biotechnology industry -- Technology application, Viral antibodies -- Technology application, Drug approval -- Technology application, Antibodies -- Technology application, Pharmaceutical industry -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

SOUTH SAN FRANCISCO, Apr 15, 2021 (GLOBE NEWSWIRE via COMTEX) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, and [...]

Published
2021

6. BrainsWay to Participate in Upcoming Investor Conferences

Subjects
Drug approval -- Technology application, Technology, Marketing, Medical equipment, Depression (Mood disorder), Major depressive disorder, Media executives, Obsessive compulsive disorder, Technology application, Banking, finance and accounting industries, Business
Abstract

PATTERSON, Mar 04, 2020 (GLOBE NEWSWIRE via COMTEX) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ('BrainsWay'), a global leader in the advanced non-invasive treatment of brain disorders, today announced that [...]

Published
2020

7. Incysus Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference

Subjects
Cancer treatment -- Technology application, Biotechnology -- Technology application, Conferences and conventions -- Technology application, Immunotherapy -- Technology application, Drug approval -- Technology application, T cells -- Technology application, Media executives, Technology application, Banking, finance and accounting industries, Business
Abstract

NEW YORK, Sep 04, 2019 (GLOBE NEWSWIRE via COMTEX) -- Incysus Therapeutics, Inc. ('Incysus'), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment [...]

Published
2019

8. Progenics Announces Addition of AZEDRA(R) (iobenguane I 131) to National Comprehensive Cancer Network Guidelines for Pheochromocytoma and Paraganglioma

Subjects
Progenics Pharmaceuticals Inc. -- Forecasts and trends -- Technology application, Cancer treatment -- Technology application, Cancer -- Drug therapy -- Technology application, Pharmaceutical industry -- Forecasts and trends -- Technology application, Drug approval -- Technology application, Market trend/market analysis, Technology application, Banking, finance and accounting industries, Business, National Comprehensive Cancer Network -- Technology application, Azedra (Medication)
Abstract

NEW YORK, Sep 17, 2018 (GLOBE NEWSWIRE via COMTEX) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]

Published
2018

9. EyeGate Announces Enrollment of First Patient in PRK Pilot Study

Subjects
Medical research -- Technology application, Drug approval -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

WALTHAM, Mass., Aug 20, 2018 (GLOBE NEWSWIRE via COMTEX) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and disorders [...]

Published
2018

10. Carp Cosmetic Surgery Center Now Offering CoolSculpting(R)

Subjects
Plastic surgery -- Technology application, Drug approval -- Technology application, Surgical clinics -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

AKRON, Ohio, Jul 02, 2018 (GLOBE NEWSWIRE via COMTEX) -- Steven S. Carp, MD, of Carp Cosmetic Surgery Center offers patients and the community a non-invasive alternative to surgical body [...]

Published
2018

11. Profound Medical Corp. Announces Chinese Food and Drug Administration Approval for Sonalleve(R)

Subjects
United States. Food and Drug Administration -- Technology application, Drug approval -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

TORONTO, May 09, May 09, 2018 (GLOBE NEWSWIRE via COMTEX) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) ('Profound' or the 'Company'), the only company to provide a therapeutics platform that provides [...]

Published
2018

12. Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA(R) for Treatment of Gastroenteropancreatic Neuroendocrine Tumors

Subjects
United States. Food and Drug Administration -- Technology application, Novartis AG -- Technology application, Medical research -- Technology application, Medicine, Experimental -- Technology application, Tumors -- Drug therapy -- Technology application, Nuclear industry -- Technology application, Drug approval -- Technology application, Pharmaceutical industry -- Technology application, Technology application, Banking, finance and accounting industries, Business, Lutathera (Medication)
Abstract

SAINT-GENIS-POUILLY, France, Jan 26, 2018 (GLOBE NEWSWIRE via COMTEX) -- First-in-class Therapy Demonstrated 79% Improvement in Progression Free Survival in NETTER-1 Phase 3 Study in Midgut NET Patients LUTATHERA marks [...]

Published
2018

13. Advanced Accelerator Applications Announces European Approval of Lutetium (177Lu) Oxodotreotide (Lutathera(R)) for Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumors

Subjects
United States. Food and Drug Administration -- Technology application, Tumors -- Technology application, Drug approval -- Technology application, Technology application, Banking, finance and accounting industries, Business, Lutathera (Medication)
Abstract

SAINT-GENIS-POUILLY, France, Sep 29, 2017 (GLOBE NEWSWIRE via COMTEX) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced that [...]

Published
2017

14. Advanced Accelerator Applications Announces Positive CHMP Opinion Recommending Approval of Lutetium 177Lu Oxodotreotide (Lutathera(R)) for Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumors

Subjects
United States. Food and Drug Administration -- Technology application, Tumors -- Technology application, Drug approval -- Technology application, Technology application, Banking, finance and accounting industries, Business, Lutathera (Medication)
Abstract

SAINT-GENIS-POUILLY, France, Jul 21, 2017 (GLOBE NEWSWIRE via COMTEX) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced that [...]

Published
2017

15. Advanced Accelerator Applications Announces European Commission Approval of SomaKit TOC(TM)

Subjects
Drug approval -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

SAINT-GENIS-POUILLY, France, Dec 15, 2016 (GLOBE NEWSWIRE via COMTEX) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) ('AAA' or 'the Company'), an international specialist in molecular nuclear medicine, today announced that following [...]

Published
2016

16. Advanced Accelerator Applications Announces Positive EMA Opinion on Application for SomaKit TOC Kit for Radiopharmaceutical Preparation of Gallium (Ga 68) Edotreotide for Gastroenteropancreatic Neuroendocrine Tumor Detection

Subjects
Positron emission tomography -- Technology application, Tumors -- Technology application, Drug approval -- Technology application, Technology application, Banking, finance and accounting industries, Business, European Union. European Commission -- Technology application
Abstract

SAINT-GENIS-POUILLY, France, Sep 16, 2016 (GLOBE NEWSWIRE via COMTEX) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) ('AAA' or 'the Company'), an international specialist in molecular nuclear medicine, today announced that the [...]

Published
2016

17. Amarin Announces Notification of Patent Allowances for U.S. Applications 12/702,889 and 13/349,153 Related to Vascepa(TM) and FDA Approved MARINE Indication

Subjects
United States. Food and Drug Administration -- Technology application, Amarin Corporation PLC -- Intellectual property -- Product development -- Technology application, Biological products industry -- Intellectual property -- Product development -- Technology application, Drug approval -- Technology application, Patents -- Technology application, Patent/copyright issue, Technology application, Banking, finance and accounting industries, Business
Abstract

Byline: Staff BEDMINSTER, N.J., and DUBLIN, Ireland, Sep 5, 2012 (GlobeNewswire via COMTEX) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to [...]

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results